Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Multiplex ligation-dependent probe amplification analysis is useful for detecting a copy number gain of the FGFR1 tyrosine kinase domain in dysembryoplastic neuroepithelial tumors.

Matsumura N, Nobusawa S, Ito J, Kakita A, Suzuki H, Fujii Y, Fukuda M, Iwasaki M, Nakasato N, Tominaga T, Natsume A, Mikami Y, Shinojima N, Yamazaki T, Nakazato Y, Hirato J, Yokoo H.

J Neurooncol. 2019 May;143(1):27-33. doi: 10.1007/s11060-019-03138-7. Epub 2019 Mar 1.

PMID:
30825062
2.

Droplet digital PCR is a powerful technique to demonstrate frequent FGFR1 duplication in dysembryoplastic neuroepithelial tumors.

Fina F, Barets D, Colin C, Bouvier C, Padovani L, Nanni-Metellus I, Ouafik L, Scavarda D, Korshunov A, Jones DT, Figarella-Branger D.

Oncotarget. 2017 Jan 10;8(2):2104-2113. doi: 10.18632/oncotarget.12881.

3.

Alterations in BRAF gene, and enhanced mTOR and MAPK signaling in dysembryoplastic neuroepithelial tumors (DNTs).

Kakkar A, Majumdar A, Kumar A, Tripathi M, Pathak P, Sharma MC, Suri V, Tandon V, Chandra SP, Sarkar C.

Epilepsy Res. 2016 Nov;127:141-151. doi: 10.1016/j.eplepsyres.2016.08.028. Epub 2016 Aug 28.

PMID:
27599148
4.

Germline and somatic FGFR1 abnormalities in dysembryoplastic neuroepithelial tumors.

Rivera B, Gayden T, Carrot-Zhang J, Nadaf J, Boshari T, Faury D, Zeinieh M, Blanc R, Burk DL, Fahiminiya S, Bareke E, Schüller U, Monoranu CM, Sträter R, Kerl K, Niederstadt T, Kurlemann G, Ellezam B, Michalak Z, Thom M, Lockhart PJ, Leventer RJ, Ohm M, MacGregor D, Jones D, Karamchandani J, Greenwood CM, Berghuis AM, Bens S, Siebert R, Zakrzewska M, Liberski PP, Zakrzewski K, Sisodiya SM, Paulus W, Albrecht S, Hasselblatt M, Jabado N, Foulkes WD, Majewski J.

Acta Neuropathol. 2016 Jun;131(6):847-63. doi: 10.1007/s00401-016-1549-x. Epub 2016 Feb 26.

5.

Genetic alterations in uncommon low-grade neuroepithelial tumors: BRAF, FGFR1, and MYB mutations occur at high frequency and align with morphology.

Qaddoumi I, Orisme W, Wen J, Santiago T, Gupta K, Dalton JD, Tang B, Haupfear K, Punchihewa C, Easton J, Mulder H, Boggs K, Shao Y, Rusch M, Becksfort J, Gupta P, Wang S, Lee RP, Brat D, Peter Collins V, Dahiya S, George D, Konomos W, Kurian KM, McFadden K, Serafini LN, Nickols H, Perry A, Shurtleff S, Gajjar A, Boop FA, Klimo PD Jr, Mardis ER, Wilson RK, Baker SJ, Zhang J, Wu G, Downing JR, Tatevossian RG, Ellison DW.

Acta Neuropathol. 2016 Jun;131(6):833-45. doi: 10.1007/s00401-016-1539-z. Epub 2016 Jan 25.

6.

BRAF V600E mutations are frequent in dysembryoplastic neuroepithelial tumors and subependymal giant cell astrocytomas.

Lee D, Cho YH, Kang SY, Yoon N, Sung CO, Suh YL.

J Surg Oncol. 2015 Mar;111(3):359-64. doi: 10.1002/jso.23822. Epub 2014 Oct 24.

PMID:
25346165
7.

Dysembryoplastic Neuroepithelial Tumor of the Septum Pellucidum and the Supratentorial Midline: Histopathologic, Neuroradiologic, and Molecular Features of 7 Cases.

Gessi M, Hattingen E, Dörner E, Goschzik T, Dreschmann V, Waha A, Pietsch T.

Am J Surg Pathol. 2016 Jun;40(6):806-11. doi: 10.1097/PAS.0000000000000600.

PMID:
26796505
8.

An epilepsy-associated glioneuronal tumor with mixed morphology harboring FGFR1 mutation.

Yamada S, Nobusawa S, Yamazaki T, Teranishi T, Watanabe S, Murayama K, Ohba S, Okabe A, Sakurai K, Urano M, Tsukamoto T, Yokoo H, Hirose Y, Abe M.

Pathol Int. 2019 Jun 19. doi: 10.1111/pin.12799. [Epub ahead of print]

PMID:
31218776
9.

A peculiar histopathological form of dysembryoplastic neuroepithelial tumor with separated pilocytic astrocytoma and rosette-forming glioneuronal tumor components.

Matyja E, Grajkowska W, Kunert P, Marchel A.

Neuropathology. 2014 Oct;34(5):491-8. doi: 10.1111/neup.12124. Epub 2014 Apr 16.

PMID:
24735014
10.

FGFR1 mutations in Rosette-forming glioneuronal tumors of the fourth ventricle.

Gessi M, Moneim YA, Hammes J, Goschzik T, Scholz M, Denkhaus D, Waha A, Pietsch T.

J Neuropathol Exp Neurol. 2014 Jun;73(6):580-4. doi: 10.1097/NEN.0000000000000080.

PMID:
24806303
11.

Dysembryoplastic neuroepithelial tumors share with pleomorphic xanthoastrocytomas and gangliogliomas BRAF(V600E) mutation and expression.

Chappé C, Padovani L, Scavarda D, Forest F, Nanni-Metellus I, Loundou A, Mercurio S, Fina F, Lena G, Colin C, Figarella-Branger D.

Brain Pathol. 2013 Sep;23(5):574-83. doi: 10.1111/bpa.12048. Epub 2013 Mar 20.

PMID:
23442159
12.

Genetic alterations related to BRAF-FGFR genes and dysregulated MAPK/ERK/mTOR signaling in adult pilocytic astrocytoma.

Pathak P, Kumar A, Jha P, Purkait S, Faruq M, Suri A, Suri V, Sharma MC, Sarkar C.

Brain Pathol. 2017 Sep;27(5):580-589. doi: 10.1111/bpa.12444. Epub 2017 Jan 6.

PMID:
27608415
13.

Internal tandem duplication mutations in the tyrosine kinase domain of FLT3 display a higher oncogenic potential than the activation loop D835Y mutation.

Marhäll A, Heidel F, Fischer T, Rönnstrand L.

Ann Hematol. 2018 May;97(5):773-780. doi: 10.1007/s00277-018-3245-5. Epub 2018 Jan 25.

14.

Landscape of chromosomal copy number aberrations in gangliogliomas and dysembryoplastic neuroepithelial tumours.

Prabowo AS, van Thuijl HF, Scheinin I, Sie D, van Essen HF, Iyer AM, Spliet WG, Ferrier CH, van Rijen PC, Veersema TJ, Thom M, Schouten-van Meeteren AY, Reijneveld JC, Ylstra B, Wesseling P, Aronica E.

Neuropathol Appl Neurobiol. 2015 Oct;41(6):743-55. doi: 10.1111/nan.12235. Epub 2015 May 19.

PMID:
25764012
15.

Comparison of formalin-fixed and snap-frozen samples analyzed by multiplex ligation-dependent probe amplification for prognostic testing in uveal melanoma.

Lake SL, Kalirai H, Dopierala J, Damato BE, Coupland SE.

Invest Ophthalmol Vis Sci. 2012 May 4;53(6):2647-52. doi: 10.1167/iovs.12-9584.

PMID:
22427594
16.

Duplications of KIAA1549 and BRAF screening by Droplet Digital PCR from formalin-fixed paraffin-embedded DNA is an accurate alternative for KIAA1549-BRAF fusion detection in pilocytic astrocytomas.

Appay R, Fina F, Macagno N, Padovani L, Colin C, Barets D, Ordioni J, Scavarda D, Giangaspero F, Badiali M, Korshunov A, M Pfister S, T W Jones D, Figarella-Branger D.

Mod Pathol. 2018 Oct;31(10):1490-1501. doi: 10.1038/s41379-018-0050-6. Epub 2018 May 25.

PMID:
29802359
17.

[Clinicopathologic features of infant dysembryoplastic neuroepithelial tumor: a case report and literature review].

Wang H, Ye JT, Yao HX, Li D, Dong Y.

Beijing Da Xue Xue Bao Yi Xue Ban. 2017 Oct 18;49(5):904-909. Review. Chinese.

18.

KIAA1549: BRAF Gene Fusion and FGFR1 Hotspot Mutations Are Prognostic Factors in Pilocytic Astrocytomas.

Becker AP, Scapulatempo-Neto C, Carloni AC, Paulino A, Sheren J, Aisner DL, Musselwhite E, Clara C, Machado HR, Oliveira RS, Neder L, Varella-Garcia M, Reis RM.

J Neuropathol Exp Neurol. 2015 Jul;74(7):743-54. doi: 10.1097/NEN.0000000000000213.

19.

Dysembryoplastic neuroepithelial tumors: MR and CT evaluation.

Ostertun B, Wolf HK, Campos MG, Matus C, Solymosi L, Elger CE, Schramm J, Schild HH.

AJNR Am J Neuroradiol. 1996 Mar;17(3):419-30.

20.

Detection of MDM2/CDK4 amplification in lipomatous soft tissue tumors from formalin-fixed, paraffin-embedded tissue: comparison of multiplex ligation-dependent probe amplification (MLPA) and fluorescence in situ hybridization (FISH).

Creytens D, van Gorp J, Ferdinande L, Speel EJ, Libbrecht L.

Appl Immunohistochem Mol Morphol. 2015 Feb;23(2):126-33. doi: 10.1097/PDM.0000000000000041.

PMID:
25679065

Supplemental Content

Support Center